DFTX compared with BTMD: revenue, margins and what each company keeps, and the suppliers and customers both name

DFTXDefinium Therapeutics, Inc.

Mkt capRevenueRevenue

BTMDbiote Corp.

Mkt capRevenueRevenue

Compare

DFTXDefinium Therapeutics, Inc.

BTMDbiote Corp.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

DFTXDefinium Therapeutics, Inc.

32.70▼−2.11%· post 32.38

Mkt cap$4.4BRevenue—Revenue—

BTMDbiote Corp.

1.21▲+7.93%· post 1.10

ClosedNov 4 '26

Mkt cap$40.2MRevenue$44MQ2 FY26Revenue$192MFY25

Compare

ClosedNov 4 '26

DFTXDefinium Therapeutics, Inc.

BTMDbiote Corp.

32.70▼−2.11%post 32.38

Price

1.21▲+7.93%post 1.10

$4.4B

Mkt cap

$40.2M

—

Revenue

$44MQ2 FY26

—

Revenue

$192MFY25

DFTX32.70▼−2.11%vsBTMD1.21▲+7.93%ClosedNov 4 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

DFTX: latest quarter not drawable. BTMD: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

No disclosed counterparties: DFTX, BTMD.

Role chip = supplier or customerSource: SEC EDGAR

Price

rebased to 0%

DFTX, solidBTMD, dashed